Life Science Consulting Services

Solutions for effective commercialization and improved market access

Drug commercialization continues to be a challenge for pharmaceutical manufacturers of all sizes and complexities. Whether you’re bringing your first drug to market or entering a new therapeutic category, determining the optimal market access strategies and putting them into action often takes more time, resources, and expertise than you’ve got on-hand. IntegriChain, together with Blue Fin Group, an IntegriChain Company, solves that problem across the full range of product archetypes, from generics to cell and gene therapy, from traditional brand to biosimilars and orphan and rare disease.

Life Science Consulting, Integration & Implementation

Our life science consulting, integration, and implementation services enable us to address your entire spectrum of commercialization and access challenges.

From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization

Interested in learning more?

Let’s talk

Case Study

Commercial Stakeholder Mapping – Blueprinting for Success

A top 10 pharmaceutical manufacturer was preparing to launch a complex oncology combination regimen with two novel agents but was faced with several unique commercial challenges.

Read the Case Study

Brochure

Consulting Services

From helping emerging companies plan and execute their first-time launch to supporting more than 65% of the top-50 largest manufacturers, IntegriChain’s consulting services enable manufacturers to get their therapies to the right patients at the right time.

Download Now

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper